ST Pharm Co.,Ltd. (KOSDAQ:237690)
102,000
+3,300 (3.34%)
Nov 20, 2025, 3:30 PM KST
ST Pharm Market Cap
ST Pharm has a market cap or net worth of 2.04 trillion as of November 19, 2025. Its market cap has increased by 2.44% in one year.
Market Cap
2.04T
Enterprise Value
2.07T
Revenue
298.11B
Ranking
n/a
PE Ratio
58.53
Stock Price
102,000.00
Market Cap Chart
Since June 23, 2016, ST Pharm's market cap has increased from 902.04B to 2.04T, an increase of 126.52%. That is a compound annual growth rate of 9.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 2.04T | 14.15% |
| Dec 30, 2024 | 1.79T | 40.37% |
| Dec 28, 2023 | 1.28T | -22.60% |
| Dec 29, 2022 | 1.65T | -36.55% |
| Dec 30, 2021 | 2.60T | 34.10% |
| Dec 30, 2020 | 1.94T | 248.32% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 41.83T |
| ALTEOGEN | 29.31T |
| SK Biopharmaceuticals | 10.20T |
| ABL Bio | 9.70T |
| Yuhan | 9.35T |
| Peptron | 7.30T |
| HLB Co., Ltd. | 6.53T |